News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Lorus Therapeutics Inc. Doesn’t Have Cash to Meet Debt Obligation
April 14, 2009
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
CALGARY, Alberta, April 13 (Reuters) - Lorus Therapeutics Inc does not have the cash it needs to meet a debt obligation due in October, the Canadian biotech company said on Monday as it reported a third-quarter loss.
Twitter
LinkedIn
Facebook
Email
Print